Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ATNM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
46 filers reported a long position in ATNM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | 1.2M | -1.4% |
| COMPASS FINANCIAL MANAGEMENT LLC | $588.2K | 600.2K | — |
| MILLENNIUM MANAGEMENT LLC | $504.3K | 514.6K | -8.9% |
| ACADIAN ASSET MANAGEMENT LLC | $485K | 496.3K | -17.4% |
| BlackRock, Inc. | $388K | 395.9K | +6.7% |
| RENAISSANCE TECHNOLOGIES LLC | $372.9K | 380.5K | -19.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $318.6K | 324.9K | -3.3% |
| TWO SIGMA INVESTMENTS, LP | $254K | 259.2K | -23.1% |
| GAGNON SECURITIES LLC | $178.5K | 182.1K | -9.5% |
| VANGUARD FIDUCIARY TRUST CO | $158.3K | 161.5K | +0.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.